A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors

Clinical trial NCT06605222 · RECRUITING

Trial details

NCT number: NCT06605222
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-10-04
Primary completion: 2026-07-31
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.